Alnylam is leading the translation of RNAi as a new class of innovative medicines, with a
General legislation pertaining to the improvement of the healthcare system to provide access to Medicare and Medicaid. General legislation pertaining to the improvement of the healthcare system to provide access to Medicare and Medicaid; PDUFA Reauthorization.
MMM - Medicare/Medicaid HCR - Health Issues
135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE CONAFAY GROUP, LLC
1001 Pennsylvania Ave, NW, 13th Floor North, Washington, DC, 20004, US
STEPHEN R CONAFAY WILLIAM A. FRANCO STEPHEN R CONAFAY WILLIAM A. FRANCO